Fadi A. Haddad

Fadi Haddad practices at Grossmont Medical Terrace - O/P Imaging - HOPD in La Mesa, California.

Fadi Haddad's NPI, 1689692956, was assigned on July 17, 2006. Fadi Haddad graduated from Jordan University of Science and Technology FOM in 1996. Fadi Haddad holds California license A80687.

Fadi Haddad's primary practice is Grossmont Medical Terrace - O/P Imaging - HOPD, at 8860 Center Dr, La Mesa, CA 91942.

Fadi Haddad's primary practice is Grossmont Medical Terrace - O/P Imaging - HOPD in La Mesa, California. Fadi Haddad is also affiliated with Sharp Grossmont Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Fadi Haddad to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Fadi Haddad practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Fadi Haddad's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Fadi Haddad is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Fadi Haddad's licenses on file in 3 states: California, Kentucky and New Jersey.

Dmand AI lists acute skin infection, endocarditis, hepatitis c, hiv/aids, joint or bone infection, pneumonia, UTI and yeast infection among the conditions Fadi Haddad treats.

CMS data shows 1,748 Medicare services from Fadi Haddad across 10 procedure codes in 2024, for 374 Medicare patients. Medicare paid $146,793 for them.

CMS counts 374 Medicare patients who saw Fadi Haddad in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Fadi Haddad's median patient age at 63, with 42% women.

In 2024, Fadi Haddad wrote 1,031 Medicare Part D claims for 184 patients. 71% of them were for generic drugs. CMS names the drug for 811 of them, across 23 drugs with 11 or more claims each, at $893,389 in total drug cost. In 2023, CMS named 560 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Fadi Haddad for performance year 2024, reported as part of a group. Fadi Haddad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Fadi Haddad as offering telehealth.

Dmand AI links 13 papers to Fadi Haddad, published from 2003 to 2021. 2019 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Bacteremia and Ceftaroline. Fadi Haddad has published most often in Antimicrob Agents Chemother. Fadi Haddad's most frequent co-authors are George Sakoulas, MD, Victor Francois Nizet, MD and Marcus John Zervos, MD.

Dmand AI links Fadi Haddad to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 267 general payments to Fadi Haddad from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Gilead Sciences, Inc. paid the most, $1,163.

Dmand AI lists 1 award for Fadi Haddad, most recently Top San Diego Physicians in 2021.

Fadi Haddad graduated from Jordan University of Science and Technology FOM in 1996.

Fadi Haddad is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.